Implementation of pharmacogenetics in psychiatry – an EU project
12.05.2025
PSY-PGx is an EU Horizon 2020 project (https://www.psy-pgx.org/PSY-PGx) that
aims to develop a genotyping approach for individualized pharmacotherapy to
improve treatment outcomes in patients with psychiatric disorders. In the project, we
aim to use Finnish Biobank data and FINDATA register data to obtain prospective
data on whether genetic variation in patients prescribed selected medications for
anxiety, depression or psychotic disorders affects various outcomes (changes in
medication, hospitalization for psychiatric and non-psychiatric conditions, and death
(especially suicides).
